Mayflower Financial Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,518
| Closed | -$212K | – | 365 |
|
|
2023
Q1 | $212K | Buy |
3,518
+5
| +0.1% | +$301 | 0.03% | 320 |
|
|
2022
Q4 | $258K | Sell |
3,513
-7
| -0.2% | -$513 | 0.04% | 287 |
|
|
2022
Q3 | $267K | Buy |
3,520
+4
| +0.1% | +$303 | 0.04% | 266 |
|
|
2022
Q2 | $244K | Buy |
3,516
+7
| +0.2% | +$486 | 0.04% | 288 |
|
|
2022
Q1 | $291K | Hold |
3,509
| – | – | 0.04% | 275 |
|
|
2021
Q4 | $263K | Buy |
3,509
+2
| +0.1% | +$150 | 0.03% | 285 |
|
|
2021
Q3 | $412K | Hold |
3,507
| – | – | 0.06% | 216 |
|
|
2021
Q2 | $778K | Hold |
3,507
| – | – | 0.11% | 128 |
|
|
2021
Q1 | $464K | Hold |
3,507
| – | – | 0.07% | 170 |
|
|
2020
Q4 | $607K | Buy |
+3,507
| New | +$607K | 0.1% | 137 |
|